I don't think that's going to be a factor in whether or not the CDC and the Advisory Committee on Immunization Practices, and ultimately Johnson Johnsons vaccineThe FDA, will make a decision, the decision of what to do with this vaccine as a vaccine product is not going to be influenced by that. It's going to be influenced by the data and safety -- not in what's going on there.